Evidence map›Paper›PMID 19038917›Full record

ArticleStroke2009

Motor recovery and axonal plasticity with short-term amphetamine after stroke.

Catherine M Papadopoulos, Shih-Yen Tsai, Veronica Guillen, Juan Ortega, Gwendolyn L Kartje, William A Wolf

Open access · bronzeAbstract read
In one paragraph

Article in Stroke, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Principles and requirements for stroke recovery science.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Review
  5. Article
  6. Article
  7. Optimizing functional outcome endpoints for stroke recovery studies.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Neurovascular remodeling in the aged ischemic brain.Journal of neural transmission (Vienna, Austria : 1996) · 2015
    Review
  16. Review
  17. Article
  18. CART peptide induces neuroregeneration in stroke rats.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2013
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Catherine M PapadopoulosEdward Hines, Jr, VA Hospital, Research Service 151, Hines, IL 60141, USA.
Shih-Yen Tsai
Veronica Guillen
Juan Ortega
Gwendolyn L Kartje
William A Wolf
Loyola University Chicago · US

Funding

Neuron Plasticity and Recovery of Function After StrokeR01NS040960 · NINDS · LOYOLA UNIVERSITY CHICAGO · PI KARTJE, GWENDOLYN LOUISE · 2001 to 2010
$2.2M
Drug-Enhanced Rehabilitation in Recovery from StrokeR01HD044772 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WOLF, WILLIAM A. · 2003 to 2007
$1.5M
Neuronal Plasticity and Recovery of Function After StrokeR56NS040960 · NINDS · LOYOLA UNIVERSITY CHICAGO · PI KARTJE, GWENDOLYN LOUISE · 2011 to 2011
$312k
Immunotherapy to Improve Functional Outcomes after Chronic Stoke in the AgedI01RX000828 · VA · EDWARD HINES JR VA HOSPITAL · PI KARTJE, GWENDOLYN LOUISE · 2012 to 2015
–
NICHD NIH HHS HD 44772NICHD NIH HHS R01 HD044772NINDS NIH HHS NS 40960NINDS NIH HHS R01 NS040960NINDS NIH HHS R56 NS040960RRD VA I01 RX000828
6 · The paper itself

Abstract

background and purposeThere is considerable debate regarding the efficacy of amphetamine to facilitate motor recovery after stroke or experimental brain injury. Different drug dosing and timing schedules and differing physical rehabilitation strategies may contribute to outcome variability. The present study was designed to ascertain (1) whether short-term amphetamine could induce long-term functional motor recovery in rats after an ischemic lesion modeling stroke in humans; (2) how different levels of physical rehabilitation interact with amphetamine to enhance forelimb-related functional outcome; and (3) whether motor improvement was associated with axonal sprouting from intact corticoefferent pathways originating in the contralesional forelimb motor cortex.

methodsAfter permanent middle cerebral artery occlusion, rats received vehicle or amphetamine during the first postoperative week (2 mg/kg, subcutaneously on Postoperative Days 2, 5, and 8). In both treatment groups, separate cohorts of rats were exposed to different levels of "physical rehabilitation" represented by a control environment, enriched environment, or enriched environment with additional sessions of focused activity. Skilled forelimb performance was assessed using the forelimb reaching task and ladder rung walk test. Anterograde tracing with biotinylated dextran amine was used to assess new fiber outgrowth to denervated motor areas.

resultsAll treatment groups showed significant motor improvement as compared with control-housed, vehicle-treated animals. However, animals housed in an enriched environment that received amphetamine paired with focused activity sessions performed significantly better than any other treatment group and was the only group to achieve complete motor recovery (ie, reached preoperative performance) by 8 weeks. This recovery was associated with axonal sprouting into deafferentated subcortical areas from contralesional projection neurons.

conclusionsThis study suggests that, after stroke, short-term pairing of amphetamine with sufficiently focused activity is an effective means of inducing long-term improvement in forelimb motor function. The anatomic data suggests that corticoefferent plasticity in the form of axonal sprouting contributes to the maintenance of motor recovery.

Indexed as

AmphetaminesAnimalsCentral Nervous System StimulantsDisease Models, AnimalDrug Administration ScheduleEfferent PathwaysForelimbGrowth ConesInfarction, Middle Cerebral ArteryMaleMotor CortexMovement DisordersNerve RegenerationNeuronal PlasticityParesisRatsAmphetaminesCentral Nervous System Stimulants

Identifiers

PMID19038917
PMCPMC3806086
OpenAlexW2125770638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.